SalioGen Therapeutics
0 followers
‌
SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.
Industries
Headquarters
Employees
Links
Org chart
Jason F. Cole
CEO & Chairman
Jason F. Cole
Collapse
Will Mcgown
Executive Director, Finance & FP&A
Jill Murray
VP, Human Resources
Joseph J. Higgins
President & Chief Scientific Officer
Jeff Kopacz
SVP of Intellectual Property & Contracts
Joe Senn
SVP & Head of R&D
Jill Murray, PHR
Vice President Human Resources
Oleg Iartchouk
Vice President, Biomarkers And Genomics
William McGowan
Executive Director, Finance And Fp&a
Subhro Guhathakurta
Executive Director, Platform Development & Genetic Engineering
Sujit Jain
Sr Director, CMC Operations
LauraLee Hughes
Director, Corporate Development & Strategy
Quinner Baltazar
Associate Director
Pat Sacco
SVP of Manufacturing, Quality & Operations
Sandeep Nema
SVP, Technical Operations
Similar companies
Springboard Collaborative
142 followers
Singularity University
8 followers
SpringWorks Therapeutics
4 followers
Owkin
4 followers
Quantum-Si
2 followers
EyePoint Pharmaceuticals
2 followers
Spero Therapeutics
2 followers
Gene by Gene
2 followers
TetraScience
7 followers
Entrada Therapeutics
1 follower
Newlight Technologies
1 follower
Discover companies